Northway Biotech
About
Northway Biotech is a global contract development and manufacturing organization (CDMO) that specializes in protein-based biologics and gene therapies. Founded in 2004, the company has over 20 years of technical expertise and operates three state-of-the-art facilities in Vilnius, Lithuania; Waltham, Massachusetts; and London, United Kingdom. Northway Biotech offers a comprehensive range of services, including cell line development, process optimization, analytical development, and cGMP manufacturing for both drug substances and products. The company manages 25–30 development projects annually, executing work from preclinical stages to commercial phases. Northway Biotech is recognized for its scientific excellence and regulatory compliance, emphasizing flexibility and responsiveness to meet customer needs. With a dedicated team of approximately 146 employees, the company generates annual revenue of $50.6 million and has successfully completed over 180 client programs.
